《中国医药科学》杂志欢迎您的投稿!.   今天是:        
王磊.灵参汤联合督灸对HIV感染者免疫重建及细胞因子TNF-α、IL-27、IL-15的影响[J].中国医药科学,2023,(20):7-11        基金项目:山东省中医药科技项目(Z-2022014)
灵参汤联合督灸对HIV感染者免疫重建及细胞因子TNF-α、IL-27、IL-15的影响
Impacts of Lingshen decoction combined with Du moxibustion on immune reconstruction and cytokines TNF-α, IL-27 and IL-15 in HIV-infected people
  
DOI:
中文关键词:  灵参汤;督灸;人类免疫缺陷病毒;免疫重建
英文关键词:Lingshen decoction; Du moxibustion; Human immunodeficiency virus; Immune reconstitution
作者单位
王磊 山东省淄博市传染病医院中医科,山东淄博 255000 
摘要点击次数: 52
全文下载次数: 38
中文摘要:
      [摘要]目的 观察用灵参汤联合督灸治疗人类免疫缺陷病毒(HIV)感染者的效果,并初步探讨其对免疫重建及血清中相关细胞因子水平的影响。方法 选取2021年1月至2022年1月于淄博市传染病医院就诊的100例HIV感染者,根据随机数表法分为对照组和观察组,每组各50例。对照组给予高效抗逆转录病毒(HARRT)治疗,观察组在对照组基础上给予灵参汤联合督灸治疗,连续治疗6个月。比较两组的总有效率、T淋巴细胞计数、肿瘤坏死因子-α(TNF-α)、白细胞介素-27(IL-27)、白细胞介素-15(IL-15)、主要症状、体征积分、世界卫生组织艾滋病生存质量测量简表(WHOQOL-HIV BREF)评分变化。结果 治疗6个月后,观察组总有效率为42.00%,高于对照组的22.00%,差异有统计学意义(P < 0.05);治疗3、6个月后,观察组CD4+T淋巴细胞计数、CD4/CD8比值高于对照组,差异有统计学意义(P < 0.05);治疗6个月后,观察组血清中TNF-α水平、症状体征总积分低于对照组,WHOQOL-HIV BREF评分、IL-27和IL-15水平高于对照组,差异有统计学意义(P < 0.05)。结论 灵参汤联合督灸治疗HIV感染有确切疗效,利于调节CD4+T淋巴细胞分化和增殖,减轻症状,提高生存治疗,初步认为其起效可能与抑制血清中TNF-α分泌、促进IL-27、IL-15的合成和分泌以抗感染、促进免疫重建有关。
英文摘要:
      [Abstract] Objective To observe the efficacy of Lingshen decoction combined with Du moxibustion in the treatment of HIV-infected people, and to preliminarily investigate its impacts on immune reconstruction and the level of related cytokines in serum. Methods A total of 100 HIV-infected patients admitted to the Infectious Disease Hospital in Zibo City from January 2021 to January 2022 were randomly divided into the control group (n=50) and the observation group (n=50). The control group was treated with highly active anti-retroviral therapy (HAART), while the observation group was treated with Lingshen decoction combined with Du moxibustion on the basis of the control group for a continuous treatment of 6 months. The overall response rate, T lymphocyte count, serum cytokines tumor necrosis factor-α (TNF-α), interleukin-27 (IL-27), interleukin-15 (IL-15), scores of main symptoms and signs, and the World Health Organization quality of life questionnaire for HIV brief version (WHOQOL-HIV BREF) were compared between the two groups. Results After 6 months of treatment, the overall response rate of the observation group was 42.00%, significantly higher than 22.00% in the control group (P < 0.05). After 3 months and 6 months of treatment, the CD4+T lymphocyte count and CD4/CD8 ratio in the observation group were both significantly higher than those in the control group (P < 0.05). After 6 months of treatment, the serum TNF-α level and the total scores of symptoms and signs in the observation group was significantly lower than that in the control group, the score of WHOQOL-HIV BREF, the level of IL-27 and IL-15 were significantly higher than that in the control group (P < 0.05). Conclusion Lingshen decoction combined with Du moxibustion has a definite therapeutic efficacy on HIV infection, which is beneficial to regulate the differentiation and proliferation of CD4+T lymphocytes, relieve symptoms and improve survival treatment. It is preliminarily considered that its effect may be related to inhibiting the secretion of TNF-α in serum, promoting the synthesis and secretion of IL-27 and IL-15, thus resisting infection and promoting immune reconstruction.
查看全文  查看/发表评论  下载PDF阅读器
关闭
关键词: 中国医药科学 中国医学 中国医学科学 中华医学 医学杂志 临床医学杂志 医学期刊 中国预防医学 中华预防医学 预防医学杂志 中国药学 药学杂志
药理杂志 中国中医 中医杂志 中华中医药 中医药杂志 中国医疗 医疗器械杂志 中国中西医结合 中国医药 医药杂志 医药期刊 医药论文 医学论文 科研论文 职称论文
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=B5024593519F267E85F13F60C88F88F219ED0B6804EED0B3CA65E0F371978D8F346EEAEFA7F3FBAAD32B1F091DC212B5AED55436EBE2A4F06EE2D6CF8D4AF23C44432284643EF16F0BED7C85EBD83D88F6C3185430BF919F1380114353083F457FA835355BA6E470E2EB52129740F13186CED76DA97E85CF2D48099BFD61FC241B99EAC0FAB3075D6D3C2752E4F094DAF525BD43EAB2F239&pcid=&cid=&jid=&yid=BA1E75DF0B7E0EB2&aid=&vid=&iid=A04140E723CB732E&sid=DF92D298D3FF1E6E&eid=708DD6B15D2464E8&fileno=20230917&flag=1&is_more=0">